574 related articles for article (PubMed ID: 33458761)
1. Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.
Nashiry A; Sarmin Sumi S; Islam S; Quinn JMW; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1387-1401. PubMed ID: 33458761
[TBL] [Abstract][Full Text] [Related]
2. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.
Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P
Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.
Mahmud SMH; Al-Mustanjid M; Akter F; Rahman MS; Ahmed K; Rahman MH; Chen W; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33847347
[TBL] [Abstract][Full Text] [Related]
4. Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint.
Cappuccio FP; Siani A
Nutr Metab Cardiovasc Dis; 2020 Jul; 30(8):1227-1235. PubMed ID: 32595085
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 and hypertension.
Ravichandran B; Grimm D; Krüger M; Kopp S; Infanger M; Wehland M
Physiol Rep; 2021 Jun; 9(11):e14800. PubMed ID: 34121359
[TBL] [Abstract][Full Text] [Related]
6. Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis.
Seeherman S; Suzuki YJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562193
[TBL] [Abstract][Full Text] [Related]
7. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
Verdecchia P; Cavallini C; Spanevello A; Angeli F
Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the Severe Acute Respiratory Syndrome Coronavirus-2 Receptor, Angiotensin-Converting Enzyme 2, in Diabetic Kidney Disease: Implications for Kidney Injury in Novel Coronavirus Disease 2019.
Gilbert RE; Caldwell L; Misra PS; Chan K; Burns KD; Wrana JL; Yuen DA
Can J Diabetes; 2021 Mar; 45(2):162-166.e1. PubMed ID: 32917504
[TBL] [Abstract][Full Text] [Related]
9. Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients.
Fagyas M; Bánhegyi V; Úri K; Enyedi A; Lizanecz E; Mányiné IS; Mártha L; Fülöp GÁ; Radovits T; Pólos M; Merkely B; Kovács Á; Szilvássy Z; Ungvári Z; Édes I; Csanádi Z; Boczán J; Takács I; Szabó G; Balla J; Balla G; Seferovic P; Papp Z; Tóth A
Geroscience; 2021 Oct; 43(5):2289-2304. PubMed ID: 34674152
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
Lite C; Ahmed SSSJ; Juliet M; Freddy AJ
Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33469663
[TBL] [Abstract][Full Text] [Related]
11. RAAS Blockade and COVID-19: Mechanistic Modeling of Mas and AT1 Receptor Occupancy as Indicators of Pro-Inflammatory and Anti-Inflammatory Balance.
Melissa Hallow K; Dave I
Clin Pharmacol Ther; 2021 Apr; 109(4):1092-1103. PubMed ID: 33506503
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders.
Nashiry MA; Sumi SS; Sharif Shohan MU; Alyami SA; Azad AKM; Moni MA
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33993223
[TBL] [Abstract][Full Text] [Related]
13. The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries.
Li N; Zhu L; Sun L; Shao G
Stem Cell Res; 2021 Mar; 51():102168. PubMed ID: 33485182
[TBL] [Abstract][Full Text] [Related]
14. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
15. The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019.
Coto E; Avanzas P; Gómez J
Eur Cardiol; 2021 Feb; 16():e07. PubMed ID: 33737961
[TBL] [Abstract][Full Text] [Related]
16. Immune Response Is Key to Genetic Mechanisms of SARS-CoV-2 Infection With Psychiatric Disorders Based on Differential Gene Expression Pattern Analysis.
Xia J; Chen S; Li Y; Li H; Gan M; Wu J; Prohaska CC; Bai Y; Gao L; Gu L; Zhang D
Front Immunol; 2022; 13():798538. PubMed ID: 35185890
[TBL] [Abstract][Full Text] [Related]
17. The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.
Wang Y; Chen B; Li Y; Zhang L; Wang Y; Yang S; Xiao X; Qin Q
J Med Virol; 2021 Mar; 93(3):1370-1377. PubMed ID: 33095513
[TBL] [Abstract][Full Text] [Related]
18. Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19.
Rieder M; Wirth L; Pollmeier L; Jeserich M; Goller I; Baldus N; Schmid B; Busch HJ; Hofmann M; Kern W; Bode C; Duerschmied D; Lother A
Am J Hypertens; 2021 Apr; 34(3):278-281. PubMed ID: 33043967
[TBL] [Abstract][Full Text] [Related]
19. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
20. Therapy With Agents Acting on the Renin-Angiotensin System and Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Gnavi R; Demaria M; Picariello R; Dalmasso M; Ricceri F; Costa G
Clin Infect Dis; 2020 Nov; 71(16):2291-2293. PubMed ID: 32442294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]